Parexel invests $1.7m into second US headquarters, to hire 264
Parexel is opening a second US headquarters in Durham, NC, a move which will see the addition of 264 jobs as part of the $1.7m investment.
Archives for June 4, 2019
'AI is the industry standard in drug discovery': Atomwise signs multi-year agreement with Eli Lilly
Atomwise signs a multi-year agreement with Eli Lilly and Company through which it will apply its patented artificial intelligence technology to support Lilly’s preclinical drug discovery efforts.
Datavant’s Health Data Link acquisition brings together ‘siloed’ worlds
Datavant acquired Health Data Link to integrate commercial data with research data to create deeper patient insights.
ASCO 2019
Relaxed eligibility criteria would double patient numbers in lung cancer studies: ASCO
Broader clinical trial eligibility criteria would double patient numbers in lung cancer studies, according to a new report from ASCO, which has been leading efforts to expand access to oncology clinical trials.
Gilead taps HitGen for drug discovery
Gilead and HitGen have signed a drug discovery collaboration – one of several recently announced agreements as HitGen sees increased demand for its technology, says CSO.
FDA says ‘threat of AMR’ behind Merck antibiotic label expansion
The US FDA approves Merck’s application to expand the label of Zerbaxa for the treatment of hospital-acquired infections to address ‘global challenge’ of AMR.
KD Pharma adds to omega-3 API production supply chain with UK site
KD Pharma adds manufacturing site in Seal Sands, UK, to manufacture omega-3-based intermediates for use in API production.